Prevalence of Metabolic Syndrome and its influence on microvascular complications in the Indian population with Type 2 Diabetes Mellitus. Sankara Nethralaya Diabetic Retinopathy Epidemiology And Molecular Genetic Study (SN-DREAMS, report 14)

Table 3 Baseline characteristics of the study population

	Metabolic Syndrome
Variables	Overall			Men			Women
	Absent	Present	p	Absent	Present	p	Absent	Present	p
	n = 371	n = 1043		n = 260	n = 490		n = 111	n = 553
Age (years)	57.0 ± 10.3	56.1 ± 9.9	0.119	57.1 ± 10.5	56.8 ± 10.5	0.664	56.8 ± 9.8	55.4 ± 9.4	0.181
HbA_1C (%)	8.3 ± 2.4	8.2 ± 2.1	0.366	8.3 ± 2.4	8.2 ± 2.1	0.475	8.2 ± 2.6	8.1 ± 2.1	0.687
Duration of diabetes (years)	6.6 ± 7.5	5.1 ± 5.7	< 0.0001	7.1 ± 8.0	5.7 ± 6.0	0.008	5.5 ± 5.6	4.6 ± 5.3	0.084
Total serum cholesterol (mg/dl)	184.5 ± 40.9	187.2 ± 40.7	0.266	178.1 ± 38.4	183.2 ± 38.4	0.081	199.5 ± 42.8	190.8 ± 42.3	0.048
Serum LDL cholesterol (mg/dl)	113.2 ± 35.9	111.8 ± 35.2	0.506	106.8 ± 33.6	106.3 ± 33.8	0.845	128.2 ± 37.2	116.7 ± 35.8	0.002
Serum Non HDL cholesterol (mg/dl)	3.7 ± 1.0	3.8 ± 1.0	0.029	3.6 ± 0.9	3.8 ± 0.9	0.009	3.9 ± 1.0	3.9 ± 1.1	0.488
Hemoglobin (gm/dl)	13.8 ± 1.8	13.8 ± 1.4	0.884	14.2 ± 1.9	14.5 ± 1.4	0.013	12.7 ± 1.3	13.1 ± 1.1	0.003

HbA_1C (%), Glycosylated hemoglobin; LDL, Low density lipoprotein; HDL, High-density lipoprotein

ISSN: 1758-5996